Surrey Heartlands

Joint Formulary & PAD

Calcifediol - Osteoporosis

You are here : Home > Formulary Search > Calcifediol - Osteoporosis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Capsules
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
NFD2
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Calcifediol
Indication :
Osteoporosis
Group Name :
Keywords :
Brand Names Include :
Domnisol
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Osteoporosis
Supporting Documents :
0

Other Indications

Below are listed other indications that Calcifediol is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Osteoporosis.

Committee Recommendations (1)

22 Nov 23 - Not Set

This drug has not yet been assessed for formulary status and is not currently on the APC work-plan.

This drug has not yet been evaluated by the Surrey Heartlands Area Prescribing Committee (APC). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. It is recommended that clinicians contact their medicines management team for further information and advice before prescribing.
The APC will consider recommending prescribing of this treatment upon submission of a formal request with its associated evidence. Clinicians can contact syheartlandsicb.APC@nhs.net  if they wish to make a submission.